je.st
news
Global Blood Therapeutics: Year-End Update On The Falling Biotech Star
2015-12-11 05:26:33| Biotech - Topix.net
After performing one of the most successful IPOs of the year, GBT continues to develop a highly promising drug with recently proven positive clinical results. The stock unreasonably plunged after an overall sickle cell skepticism triggered by American Society of Hematology annual meeting and thus reached an attractive entry point for risk-tolerant investors.
Tags: global
star
update
blood
Category:Biotechnology and Pharmaceuticals